Letter to the EditorKounis syndrome: A manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material
Introduction
Acute myocardial infarction following stent implantation is an emerging serious clinical problem in patients treated with DES [1]. Recent data have shown that a small but increasing number of patients, with implanted DES, may develop simultaneous, multivessel, repeated, remote and peripheral arterial thrombosis [2]. Clinical and pathology findings point towards a possible hypersensitivity reaction to DES components manifesting as Kounis syndrome [3]. Current DES components include the metal stent itself which is made from 316L stainless steel containing nickel, chromium, molybdenum, the polymer coating, and the impregnated drugs which for today are: the antimicrotubule, antineoplastic agent paclitaxel and the anti-inflammatory, immunosuppressive and antiproliferative agent rapamycin. For Endeavor zotarolimus-eluting stent which is a newly synthesized sirolimus analogue and received FDA approval recently long results and side effects from its use have not been established [4]. Other agents such as everolimus, biolimus, tacrolimus pimecrolimus etc. are currently undergoing safety and efficacy trials either impregnated in metal stents or used in transplant recipients in order to prevent rejection. All these agents either separately or synergistically seem to be able to induce hypersensitivity reactions and hypersensitivity coronary events [4]. Additionally, patients we implanted stents, receive clopidogel and aspirin, two well known antigenic substances, as antiplatelet agents.
We report a patient who developed acute myocardial infarction, in the stented coronary area, following allergic reaction to an additional antigenic agent (a non-anionic contrast material) during radiographic examination.
Section snippets
Case report
A 48-year-old heavy smoker man was referred for investigation for recurrent renal colic and low back pain. During his admission routine laboratory investigation revealed no abnormality and he was scheduled for abdominal contrast-enhanced CT-scan and intravenous urography. The patient did not recall any previous history of drug allergy, rhinitis, eczema, dermatitis, bronchial asthma and diabetes mellitus.
However, six months previously he had been admitted to another hospital for an acute
Discussion
Patients undergoing DES implantation receive five different substances which can act as potential antigens. These substances include the nickel strut, the polymer, the eluted drug, plus aspirin and clopidogrel. Hypersensitivity inflammation is initiated by antigens cross-bridging their corresponding, receptor-bound, immunoglobulin IgE antibodies on the mast cell or basophile cell surface. These cells degranulate and release their mediators when the critical number of bridged IgE antibodies
Acknowledgement
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [15].
References (15)
- et al.
Acute myocardial infarction and Kounis syndrome
Int J Cardiol
(2009) - et al.
Kounis syndrome and simultaneous multivessel acute coronary syndromes after successful drug-eluting stent implantation
Int J Cardiol
(2008) - et al.
IgE antibody quantification and the probability of wheeze in preschool children
J Allergy Clin Immunol
(2005) - et al.
Kounis syndrome secondary to amoxicillin/clavulanic acid use
Int J Cardiol
(2008) Serum tryptase levels and Kounis syndrome
Int J Cardiol
(2007)- et al.
Kounis syndrome associated with hypersensitivity to hymenoptera stings
Int J Cardiol
(2007) - et al.
Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration
Int J Cardiol
(2007)
Cited by (40)
Analysis of clinical characteristics of Kounis syndrome induced by contrast media
2022, American Journal of Emergency MedicineCitation Excerpt :Treatment of these patients included steroids (25 cases), antihistamines (14), nitrates (5 cases), epinephrine (15 cases), dopamine (6 cases), antiplatelet drugs (5 cases), and anticoagulant drugs (5 cases) (Table 2). Eight patients underwent revascularization, including percutaneous transluminal coronary angioplasty (5 cases) [5,8,15,18,23] and coronary artery stenting (3 cases) [16,17,24]. One patient undergoing cardiopulmonary resuscitation [21].
Kounis syndrome induced by contrast media: A case report and review of literature
2019, European Journal of Radiology OpenCitation Excerpt :Low-osmolar non-anionic contrast materials are less toxic than anionic and monomeric contrast materials, however, most of the KS cases described in Table 1 were caused by low-osmolar non-ionic contrast materials. Almost all of these cases have been reported by cardiologists, emergency physicians, or allergists [31–39]. These reports, including the present case, clearly show that not only intracoronary injection during CAG but also intravenous injection of contrast materials can cause any type of KS.
Intraprocedure Type II Kounis Syndrome Secondary to Radioiodine Contrast During Coronary Angiography
2018, Canadian Journal of Cardiology